{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:41:48Z","timestamp":1790116908860,"version":"4.0.1"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T00:00:00Z","timestamp":1559606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005363","name":"Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["20020170100562BA"],"award-info":[{"award-number":["20020170100562BA"]}],"id":[{"id":"10.13039\/501100005363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2014-1049"],"award-info":[{"award-number":["PICT-2014-1049"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2016-0629"],"award-info":[{"award-number":["PICT-2016-0629"]}],"id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01267","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T02:13:20Z","timestamp":1559614400000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":87,"title":["IL-10\/STAT3\/SOCS3 Axis Is Involved in the Anti-inflammatory Effect of Benznidazole"],"prefix":"10.3389","volume":"10","author":[{"given":"\u00c1gata C.","family":"Cevey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico N.","family":"Penas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina D.","family":"Alba Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo A.","family":"Mirkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora B.","family":"Goren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,4]]},"reference":[{"key":"B1","unstructured":"World Health OrganizationWHO Chagas disease (American trypanosomiasis).2017"},{"key":"B2","first-page":"1","volume-title":"Control of Chagas disease","year":"2002"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1128\/AAC.49.4.1521-1528.2005","article-title":"Treatment with benznidazole during the chronic phase of experimental chagas' disease decreases cardiac alterations","volume":"49","author":"Garcia","year":"2005","journal-title":"Antimicrob Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.7326\/0003-4819-144-10-200605160-00006","article-title":"Long-term cardiac outcomes of treating chronic chagas disease with benznidazole versus no treatment: a nonrandomized trial","volume":"144","author":"Viotti","year":"2006","journal-title":"Ann Intern Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.imbio.2014.12.006","article-title":"Etiological treatment of chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events","volume":"220","author":"Campi-Azevedo","year":"2015","journal-title":"Immunobiology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijpddr.2015.12.001","volume":"6","author":"Cevey","year":"2016","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.4049\/jimmunol.167.6.3422","article-title":"Trypanocidal drug benznidazole impairs lipopolysaccharide induction of macrophage nitric oxide synthase gene transcription through inhibition of nf-kappaB activation","volume":"167","author":"Piaggio","year":"2001","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.lfs.2004.09.013","article-title":"Benznidazole, a drug used in chagas' disease, ameliorates LPS-induced inflammatory response in mice","volume":"76","author":"Pascutti","year":"2004","journal-title":"Life Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.exppara.2016.05.005","article-title":"Innate immunomodulation to trypanosomatid parasite infections","volume":"167","author":"Dos-Santos","year":"2016","journal-title":"Exp Parasitol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coi.2016.10.005","article-title":"Early innate immune responses to bacterial LPS.","author":"Rosadini","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.coph.2006.01.010","article-title":"Understanding and exploiting the endogenous interleukin-10\/STAT3-mediated anti-inflammatory response","volume":"6","author":"Murray","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10549-011-1855-x","article-title":"Role of interleukin-10 in breast cancer","volume":"133","author":"Hamidullah","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"B14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/mi.2011.7","article-title":"The role of IL-10 in immune regulation during M. tuberculosis infection","volume":"4","author":"Redford","year":"2011","journal-title":"Mucosal Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s12026-011-8262-6","article-title":"Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy","volume":"51","author":"Sato","year":"2011","journal-title":"Immunol Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/82_2010_96","article-title":"The role of IL-10 in regulating immunity to persistent viral infections","volume":"350","author":"Wilson","year":"2011","journal-title":"Curr Top Microbiol Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.4049\/jimmunol.169.5.2253","article-title":"Shaping gene expression in activated and resting primary macrophages by IL-10","volume":"169","author":"Lang","year":"2002","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"567","DOI":"10.4049\/jimmunol.172.1.567","article-title":"Signal Transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages","volume":"172","author":"Williams","year":"2004","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/bfgp\/elt028","article-title":"The IL-10\/STAT3-mediated anti-inflammatory response: recent developments and future challenges","volume":"12","author":"Hutchins","year":"2013","journal-title":"Brief Funct Genomics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.smim.2014.10.004","article-title":"SOCS3 and STAT3, major controllers of the outcome of infection with Mycobacterium tuberculosis","volume":"26","author":"Rottenberg","year":"2014","journal-title":"Semin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.intimp.2016.05.017","article-title":"Isocyperol, isolated from the rhizomes of cyperus rotundus, inhibits LPS-induced inflammatory responses via suppression of the NF-\u03baB and STAT3 pathways and ROS stress in LPS-stimulated RAW 264","volume":"38","author":"Seo","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4049\/jimmunol.1401024","article-title":"Adenosine 5\u2032-monophosphate\u2013activated protein kinase regulates IL-10\u2013mediated anti-inflammatory signaling pathways in macrophages","volume":"194","author":"Zhu","year":"2015","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.118.035047","article-title":"IL-10-STAT3-galectin-3 axis is essential for osteopontin-producing reparative macrophage polarization after myocardial infarction","volume":"138","author":"Shirakawa","year":"2018","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.intimp.2016.05.010","article-title":"Resokaempferol-mediated anti-inflammatory effects on activated macrophages via the inhibition of JAK2\/STAT3, NF-\u03baB and JNK\/p38 MAPK signaling pathways","volume":"38","author":"Yu","year":"2016","journal-title":"Int Immunopharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.bbamcr.2014.01.021","article-title":"MafB is a downstream target of the IL-10\/STAT3 signaling pathway, involved in the regulation of macrophage de-activation","volume":"1843","author":"Gemelli","year":"2014","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-017-0843-4","article-title":"NOX2 deficiency alters macrophage phenotype through an IL-10\/STAT3 dependent mechanism: implications for traumatic brain injury","volume":"14","author":"Barrett","year":"2017","journal-title":"J Neuroinflammation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1046\/j.1365-2567.2001.01235.x","article-title":"Mechanisms of interleukin-10-mediated immune suppression","volume":"103","author":"Akdis","year":"2001","journal-title":"Immunology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/eji.201646710","article-title":"The IL\u221210\/STAT3 axis: contributions to immune tolerance by thymus and peripherally derived regulatory t-cells","volume":"47","author":"Schmetterer","year":"2017","journal-title":"Eur J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep09100","article-title":"Genomic analysis of LPS-stimulated myeloid cells identifies a common pro-inflammatory response but divergent IL-10 anti-inflammatory responses","volume":"5","author":"Hutchins","year":"2015","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1006809","DOI":"10.1371\/journal.ppat.1006809","article-title":"STAT3 expression by myeloid cells is detrimental for the T-cell-mediated control of infection with Mycobacterium tuberculosis","volume":"14","author":"Gao","year":"2018","journal-title":"PLoS Pathog."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e79445","DOI":"10.1371\/journal.pone.0079445","article-title":"IL-10 inhibits the NF-\u03baB and ERK\/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in trypanosoma cruzi-infected cardiomyocytes","volume":"8","author":"Hovsepian","year":"2013","journal-title":"PLoS ONE."},{"key":"B32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","article-title":"Regulation of the inflammatory response in cardiac repair","volume":"110","author":"Frangogiannis","year":"2012","journal-title":"Circ Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep21244","article-title":"Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes","volume":"6","author":"Barry","year":"2016","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.intimp.2014.12.035","article-title":"IL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells","volume":"24","author":"Cianciulli","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.3892\/mmr.2018.9547","article-title":"Interleukin 10 promotes proliferation and migration, and inhibits tendon differentiation via the JAK\/Stat3 pathway in tendon derived stem cells in vitro","volume":"18","author":"Deng","year":"2018","journal-title":"Mol Med Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1074\/jbc.M112.386573","article-title":"Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation","volume":"288","author":"Braun","year":"2013","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.it.2009.09.009","article-title":"Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function","volume":"30","author":"Palmer","year":"2009","journal-title":"Trends Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fimmu.2014.00058","article-title":"SOCS3, a major regulator of infection and inflammation","volume":"5","author":"Carow","year":"2014","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/ni938","article-title":"IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages","volume":"4","author":"Yasukawa","year":"2003","journal-title":"Nat Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.2741\/4054","article-title":"IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?","volume":"17","author":"Camporeale","year":"2012","journal-title":"Front Biosci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1172\/JCI118861","article-title":"Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4+Th1-like responses","volume":"98","author":"Berg","year":"1996","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","article-title":"Stattic: A small-molecule inhibitor of STAT3 activation and dimerization","volume":"13","author":"Schust","year":"2006","journal-title":"Chem Biol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"B44","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin Chem"},{"key":"B45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1385\/0-89603-268-X:9","article-title":"The bradford method for protein quantitation","volume":"32","author":"Kruger","year":"1994","journal-title":"Methods Mol Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.freeradbiomed.2007.04.026","article-title":"Methods to detect nitric oxide and its metabolites in biological samples","volume":"43","author":"Bryan","year":"2007","journal-title":"Free Radic Biol Med"},{"key":"B47","doi-asserted-by":"crossref","first-page":"30114","DOI":"10.1074\/jbc.271.47.30114","article-title":"Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes","volume":"271","author":"D\u00edaz-Guerra","year":"1996","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1128\/iai.71.3.1185-1193.2003","article-title":"Evidence that development of severe cardiomyopathy in human chagas' disease is due to a Th1-specific immune response","volume":"71","author":"Gomes","year":"2003","journal-title":"Infect Immun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1128\/IAI.72.9.5283-5291.2004","article-title":"Monocytes from patients with indeterminate and cardiac forms of chagas' disease display distinct phenotypic and functional characteristics associated with morbidity","volume":"72","author":"Souza","year":"2004","journal-title":"Infect Immun"},{"key":"B51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ccl.2016.08.013","article-title":"Chagas cardiomyopathy","volume":"35","author":"Benziger","year":"2017","journal-title":"Cardiol Clin"},{"key":"B52","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat chagas' disease (American trypanosomiasis)","volume":"25","author":"Castro","year":"2006","journal-title":"Hum Exp Toxicol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1590\/S0074-02762002000100001","article-title":"A critical review on chagas disease chemotherapy","volume":"97","author":"Rodriques Coura","year":"2002","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1586\/14787210.7.2.157","article-title":"Side effects of benznidazole as treatment in chronic chagas disease: fears and realities","author":"Viotti","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"B55","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1128\/AAC.01401-12","article-title":"Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease","volume":"57","author":"Pinazo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B56","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1590\/S0074-02762009000900021","article-title":"Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification.","volume":"104","author":"Rassi","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"B57","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0006-291X(02)03071-1","article-title":"Cloning and characterization of a functional promoter of the human SOCS-3 gene","volume":"301","author":"He","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"B58","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.4049\/jimmunol.1000773","article-title":"The PPE18 protein of Mycobacterium tuberculosis inhibits NF-\u03baB\/rel-mediated proinflammatory cytokine production by upregulating and phosphorylating suppressor of cytokine signaling 3 protein","volume":"186","author":"Nair","year":"2011","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e1003442","DOI":"10.1371\/journal.ppat.1003442","article-title":"Critical and independent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosis","volume":"9","author":"Carow","year":"2013","journal-title":"PLoS Pathog"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1126\/science.162.3859.1277","article-title":"Deficiency of reduced nicotinamide-adenine dinucleotide oxidase in chronic granulomatous disease","volume":"162","author":"Baehner","year":"1968","journal-title":"Science."},{"key":"B61","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1179\/135100001101536328","article-title":"Time-dependent oxidative stress caused by benznidazole","volume":"6","author":"Pedrosa","year":"2001","journal-title":"Redox Rep"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e1006928","DOI":"10.1371\/journal.ppat.1006928","article-title":"ROS and trypanosoma cruzi: fuel to infection, poison to the heart","volume":"14","author":"Paiva","year":"2018","journal-title":"PLoS Pathog"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s00018-016-2234-x","article-title":"SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?","volume":"73","author":"Mahony","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.4049\/jimmunol.168.12.6404","article-title":"Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation","volume":"168","author":"Berlato","year":"2002","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"6316","DOI":"10.1074\/jbc.M508608200","article-title":"Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor \u03b1 and nitric oxide production by macrophages","volume":"281","author":"Qasimi","year":"2006","journal-title":"J Biol Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.phytochem.2011.12.001","article-title":"The inhibition of lipopolysaccharide-induced macrophage inflammation by 4 compounds in hypericum perforatum extract is partially dependent on the activation of SOCS3","volume":"76","author":"Huang","year":"2012","journal-title":"Phytochemistry"},{"key":"B67","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1136\/ard.2011.154815","article-title":"A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis","volume":"70","author":"Veenbergen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"9558","DOI":"10.1074\/jbc.270.16.9558","article-title":"Interleukin (IL)-10 inhibits nuclear factor \u03baB (NF\u03baB) activation in human monocytes","volume":"270","author":"Wang","year":"1995","journal-title":"J Biol Chem"},{"key":"B69","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/00024382-199812000-00002","article-title":"Interleukin-10 stabilizes inhibitory kappa b-alpha in human monocytes","volume":"10","author":"Shames","year":"1998","journal-title":"Shock"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1006\/cyto.2000.0721","article-title":"Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages","volume":"12","author":"Raychaudhuri","year":"2000","journal-title":"Cytokine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01267\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T02:13:25Z","timestamp":1559614405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01267\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,4]]},"references-count":70,"alternative-id":["10.3389\/fimmu.2019.01267"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01267","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,4]]},"article-number":"1267"}}